Company Filing History:
4 out of 4 
3 out of 4 
1 out of 45 Years Active: 2012-2019
Title: Innovations of Wei-wei Chang in Neuropharmacology
Introduction
Wei-wei Chang is a prominent inventor based in Boston, MA, known for his significant contributions to the field of neuropharmacology. With a total of 10 patents to his name, Chang has developed innovative methods for delivering pharmaceuticals that target cranial nerves and treat neurodegenerative disorders. His work has the potential to revolutionize treatment approaches in these critical areas of health.
Latest Patents
Chang's latest patents include a method for cranial delivery of pharmaceuticals, which allows for the rapid delivery of active compounds to innervate cranial nerves. This method also encompasses a technique for treating diseases or conditions by topically applying a pharmaceutical composition to the face, excluding the palpebral part of the eye. Another notable patent addresses the treatment of symptoms related to neurodegenerative disorders through pharmacological dermal activation of cranial nerves. This method involves the topical administration of a composition containing a sex steroid or a cannabinoid to specific anatomical locations, effectively targeting both motor and non-motor symptoms.
Career Highlights
Throughout his career, Wei-wei Chang has worked with notable companies such as Glia, LLC and Asan Laboratories Company. His innovative approaches and research have positioned him as a key figure in the development of new therapeutic strategies in neuropharmacology.
Collaborations
Chang has collaborated with esteemed colleagues, including Kenneth I. Sawyer and Yih-Lin Chung, contributing to a rich exchange of ideas and advancements in their field.
Conclusion
Wei-wei Chang's work exemplifies the intersection of innovation and healthcare, particularly in the treatment of neurodegenerative conditions. His patents reflect a commitment to improving patient outcomes through targeted pharmaceutical delivery methods.